{"transactions":[{"id":921050,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":177000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":177000},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921049,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921048,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 140,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 140,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921047,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14136,"price":4.24,"value":59936.64,"ownership":{"direct":true},"balance_after":127665,"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921046,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":58050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,363 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":141801,"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":1283742,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2025 such that the option is fully vested on January 31, 2029."}],"balance_after":200000,"derivative":{"exercise_price":3.06,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283741,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283740,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":46800,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283739,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14134,"price":3.06,"value":43250.04,"ownership":{"direct":true},"balance_after":81388,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283738,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":11250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects shares received upon the satisfaction of performance criteria and time-vesting requirements associated with previously granted performance restricted stock units (\"PSUs\")."}],"balance_after":95522,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283737,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":46800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,110 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":84272,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1660767,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-03T02:24:58.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":225200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028."}],"balance_after":225200,"derivative":{"exercise_price":4.16,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":225200},"source":{"system":"sec-edgar","filing":"0000950170-24-010967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024010967/ownership.xml","form_type":"4"}},{"id":1660766,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T02:24:58.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":93600,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0000950170-24-010967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024010967/ownership.xml","form_type":"4"}},{"id":1660765,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-02-03T02:24:58.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":14029,"price":3.843,"value":53913.447,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022."}],"balance_after":35362,"source":{"system":"sec-edgar","filing":"0000950170-24-010967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024010967/ownership.xml","form_type":"4"}},{"id":1660764,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-02-03T02:24:58.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":46800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,591 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":49391,"source":{"system":"sec-edgar","filing":"0000950170-24-010967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017024010967/ownership.xml","form_type":"4"}},{"id":2035141,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T23:28:58.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":196600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027."}],"balance_after":196600,"derivative":{"exercise_price":4.63,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":196600},"source":{"system":"sec-edgar","filing":"0000899243-23-003604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924323003604/doc4.xml","form_type":"4"}},{"id":2035140,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T23:28:58.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":140400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026."}],"balance_after":140400,"derivative":{"underlying":"Common Stock","underlying_shares":140400},"source":{"system":"sec-edgar","filing":"0000899243-23-003604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924323003604/doc4.xml","form_type":"4"}},{"id":2415831,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T22:15:32.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022."}],"balance_after":190000,"derivative":{"exercise_price":7.14,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0000899243-22-004181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924322004181/doc4.xml","form_type":"4"}},{"id":2888244,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-01T21:55:55.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":160050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021."}],"balance_after":160050,"derivative":{"exercise_price":73,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":160050},"source":{"system":"sec-edgar","filing":"0000899243-21-003872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924321003872/doc4.xml","form_type":"4"}}]}